SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Emergent Health Corp (EMGE) .
本页证实的标准:
- VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。
SharesGrow 综合评分： 19/100 其中 0/7 项标准通过。
SharesGrow 7-Criteria Score
✗
健康
0/100
Debt-to-Equity & liquidity
→ Health
估值概览 — EMGE
估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.02
EV/EBITDA0.0
每股数据
EPS (TTM)$0.00
每股账面价值$0.00
每股营收$0.00
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%
P/E Ratio & Earnings Yield
每股收益 (EPS) 历史
| Year |
EPS（稀释） |
营收 |
净利润 |
净利润率 |
| 2012 |
$0.01 |
$1.37K |
$132.00 |
9.7% |
| 2013 |
$0.00 |
$989.84K |
$121.03K |
12.2% |
| 2019 |
$0.00 |
$183.12K |
$-67.5K |
-36.9% |
| 2020 |
$0.00 |
$167.19K |
$-79.13K |
-47.3% |
| 2021 |
$-0.01 |
$119.57K |
$-288.76K |
-241.5% |
| 2022 |
$-0.01 |
$574.61K |
$-2.11M |
-366.8% |
| 2023 |
$0.00 |
$1.64M |
$-1.63M |
-99.6% |
